Samsung Biologics unveils deal with Pfizer

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The South Korean company Samsung Biologics has revealed that is has closed manufacturing deals with Pfizer that amount to a total of $897 million.

Actual Topics